01/30/2024
π Research Opportunity Alert! π§ β¨
Curious about groundbreaking OCD research in BC? π¨π¦ We're investigating the effects of celecoxib, an anti-inflammatory medication, when added to standard treatments for OCD. Here's what you need to know:
π What's the study about?
Exploring how celecoxib, a twice-daily medication, influences OCD symptoms in children over 12 weeks. We're delving into the potential benefits of this non-steroidal anti-inflammatory drug.
π What happens in the study?
Participants will complete a phone interview, three in-person/remote visits, and online questionnaires. Blood work, height, and weight measurements ensure safety and track progress. Participants may receive celecoxib or a placebo for 12 weeks, with an optional extension. No interruption to current OCD treatments required!
π Who can participate?
Children & youth (7-18) in BC with diagnosed OCD and current symptoms. Participation is voluntary, and it won't affect your current medical care.
Ready to be a part of cutting-edge research? π Learn more here!ππ¬
https://www.bcchr.ca/POP/our-research/ace-ocd